Form 4: Orgenesis Inc. Director, Mark Goodman, Acquires Stock Options
SEC Form 4 Filing
Director Mark Goodman acquired stock options in Orgenesis Inc. on June 27, 2024.
Summary
- On June 27, 2024, Mark Goodman, a director of Orgenesis Inc., acquired stock options.
- The options grant the right to buy 6,250 shares of common stock at an exercise price of $0.63.
- The options vest equally over the next three years, contingent upon continued service.
- Following the transaction, Goodman directly owns 6,250 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option acquisition.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/27/2024 | Date of stock option transaction |
| 06/26/2034 | Expiration date of the stock options |
| 07/19/2024 | Date of Form 4 filing |
Keywords
stock options, director, Orgenesis Inc., ORGS, Form 4, beneficial ownership, Mark Goodman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.